Mol Biotechnol. 2024 May 11. doi: 10.1007/s12033-024-01158-x. Online ahead of print. ABSTRACT We aim to screen and analyze the ferroptosis inflammation-related hub genes associated with …
Pediatr Res. 2024 May 11. doi: 10.1038/s41390-024-03232-1. Online ahead of print. ABSTRACT BACKGROUND: To investigate association of prenatal risk factors and neonatal outcomes of preterm …
Pediatr Res. 2024 May 11. doi: 10.1038/s41390-024-03263-8. Online ahead of print. NO ABSTRACT PMID:38734815 | DOI:10.1038/s41390-024-03263-8
J Intellect Disabil Res. 2024 May 11. doi: 10.1111/jir.13146. Online ahead of print. ABSTRACT BACKGROUND: The classification of mental, behavioural and neurodevelopmental disorders in the …
Adm Policy Ment Health. 2024 May 11. doi: 10.1007/s10488-024-01381-3. Online ahead of print. ABSTRACT We face increasing demand for greater access to effective routine mental …
Psychopharmacology (Berl). 2024 May 11. doi: 10.1007/s00213-024-06603-y. Online ahead of print. ABSTRACT RATIONALE: Valproic acid (VPA) is commonly used as a second-line mood stabilizer or …
Nutrients. 2024 Apr 26;16(9):1303. doi: 10.3390/nu16091303. ABSTRACT BACKGROUND: Early-life vitamin D is a potentially modifiable risk factor for the development of eczema, but there is …
Nutrients. 2024 Apr 29;16(9):1340. doi: 10.3390/nu16091340. ABSTRACT (1) Background: The literature regarding orthorexia nervosa (ON) has well documented the association with other mental disorders, such …
Mol Genet Metab. 2024 Apr 27;142(2):108486. doi: 10.1016/j.ymgme.2024.108486. Online ahead of print. ABSTRACT Empagliflozin has been successfully repurposed for treating neutropenia and neutrophil dysfunction in …
Int J Med Inform. 2024 May 8;188:105474. doi: 10.1016/j.ijmedinf.2024.105474. Online ahead of print. ABSTRACT BACKGROUND: Generative artificial intelligence (GAI) is revolutionizing healthcare with solutions for …
